Tremfya and Blood glucose decreased - a phase IV clinical study of FDA data

Summary:

Blood glucose decreased is reported only by a few people who take Tremfya.

The phase IV clinical study analyzes which people take Tremfya and have Blood glucose decreased. It is created by eHealthMe based on reports of 12,066 people who have side effects while taking Tremfya from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

12,066 people reported to have side effects when taking Tremfya.
Among them, 2 people (0.02%) have Blood glucose decreased.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 12,073 Tremfya users for its effectiveness, alternative drugs and more.

What is Blood glucose decreased?

Blood glucose decreased is found to be associated with 1,990 drugs and 1,312 conditions by eHealthMe.

Number of Tremfya and Blood glucose decreased reports submitted per year:

Could Tremfya cause Blood glucose decreased?

Gender of people who have Blood glucose decreased when taking Tremfya *:

female: 100 %
male: 0.0 %

Age of people who have Blood glucose decreased when taking Tremfya *:

Common drugs people take besides Tremfya *:

Lantus: 1 person, 50.00%
Byetta: 1 person, 50.00%

Common side effects people have besides Blood glucose decreased *:

Subdural Haematoma (blood collects between the skull and the surface of the brain): 1 person, 50.00%
Sleep Disorder: 1 person, 50.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%
Ill-Defined Disorder: 1 person, 50.00%
Hypotension (abnormally low blood pressure): 1 person, 50.00%
Head Injury: 1 person, 50.00%
Fall: 1 person, 50.00%
Drug Ineffective: 1 person, 50.00%
Blood Glucose Increased: 1 person, 50.00%
Acidosis (build-up of carbon dioxide in the blood): 1 person, 50.00%

Common conditions people have *:

Type 2 Diabetes: 1 person, 50.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tremfya and have Blood glucose decreased?

Check whether Blood glucose decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Blood glucose decreased and when was it recovered:

Blood glucose decreased in Tremfya

Expand to all the drugs that have ingredients of guselkumab:

Blood glucose decreased and drugs with ingredients of guselkumab

Alternative drugs to, pros and cons of Tremfya:

Tremfya (12,073 reports)

Common Tremfya side effects:

Psoriasis (immune-mediated disease that affects the skin): 1,065 reports
Drug ineffective: 973 reports
Joint pain: 342 reports
Rashes (redness): 326 reports
Itching: 245 reports
Headache (pain in head): 237 reports
Pneumonia: 234 reports
Pain: 232 reports
Diarrhea: 205 reports

Browse all side effects of Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Blood glucose decreased treatments and more:

Blood glucose decreased (49,758 reports)

COVID vaccines that are related to Blood glucose decreased:

Common drugs associated with Blood glucose decreased:

All the drugs that are associated with Blood glucose decreased:

Blood glucose decreased (1,990 drugs)

Common conditions associated with Blood glucose decreased:

Type 2 diabetes: 12,382 reports
Diabetes: 6,513 reports
Type 1 diabetes: 3,050 reports

All the conditions that are associated with Blood glucose decreased:

Blood glucose decreased (1,312 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on guselkumab (the active ingredients of Tremfya) and Tremfya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.